We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00376610
Recruitment Status : Completed
First Posted : September 15, 2006
Last Update Posted : July 4, 2007
Sponsor:
Information provided by:

Study Description
Brief Summary:
ASR/Re-cap versus 28 MoM

Condition or disease Intervention/treatment Phase
Bearings Device: ASR/Re-cap Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty
Arms and Interventions


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of THA
  • ASA I-II
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Collum femurs < 2 cm
  • Cysts > 1 cm
  • Caput necrose
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00376610


Locations
Denmark
Frederiksberg University Hospital
Frederiksberg, Copenhagen, Denmark, 2000
Sponsors and Collaborators
Frederiksberg University Hospital
Investigators
Study Director: Arne Borgwardt Frederiksberg Univesity Hospital
More Information

ClinicalTrials.gov Identifier: NCT00376610     History of Changes
Other Study ID Numbers: KF1127957
First Posted: September 15, 2006    Key Record Dates
Last Update Posted: July 4, 2007
Last Verified: July 2007